InDex’s advisory boards support the strong InDex team, ensure clinical relevance of InDex’s studies, support increased awareness and enable outreach to achieve broad patient recruitment. Many leading experts are also involved in the development of the trial design and will be involved in implementation of the phase III program.

Brian G. Feagan, Prof., MD

London Health Sciences Centre, Western University, London, Ontario, Canada

 

Christina Ha, Ass. Prof., MD

Cedars-Sinai Medical Center, Los Angeles, California, USA

 

Florian Rieder, MD

Cleveland Clinic, Cleveland, Ohio, USA

 

David T. Rubin, Prof., MD

University of Chicago, Chicago, Illinois, USA

 

William J. Sandborn, Prof., MD

University of California, San Diego, California, USA

 

Bruce E. Sands, Prof., MD

The Mount Sinai Hospital, New York, New York, USA